Chiasma, Inc. (CHMA) Social Stream
Chiasma Inc (CHMA) Price Targets From Analysts
Use the tables below to see what analysts covering Chiasma Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 5 | $18 | $4.5 | $9.1 | $3.76 | 142.02% |
The Trend in the Analyst Price Target
Over the past 14 months, CHMA's average price target has gone down $3.3.
CHMA reports an average of 205.46% for its upside potential over the past 14 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-06 | 5 | 18 | 4.5 | 9.10 | 3.760 | 142.02% |
| 2021-08-05 | 5 | 18 | 4.5 | 9.10 | 3.760 | 142.02% |
| 2021-08-01 | 5 | 18 | 4.5 | 9.10 | 4.000 | 127.5% |
| 2021-07-24 | 5 | 18 | 4.5 | 9.10 | 4.240 | 114.62% |
| 2021-07-17 | 5 | 18 | 4.5 | 9.10 | 4.370 | 108.24% |
| 2021-07-10 | 5 | 18 | 4.5 | 9.10 | 4.480 | 103.12% |
| 2021-06-29 | 5 | 18 | 4.5 | 9.10 | 4.740 | 91.98% |
| 2021-06-26 | 5 | 18 | 4.5 | 9.10 | 4.760 | 91.18% |
| 2021-06-13 | 5 | 18 | 4.5 | 9.10 | 4.190 | 117.18% |
| 2021-06-05 | 5 | 18 | 4.5 | 9.10 | 4.160 | 118.75% |
| 2021-05-21 | 5 | 18 | 4.5 | 9.10 | 4.330 | 110.16% |
| 2021-05-15 | 5 | 18 | 4.5 | 9.10 | 4.010 | 126.93% |
| 2021-05-08 | 5 | 18 | 4.5 | 9.10 | 4.030 | 125.81% |
| 2021-04-25 | 5 | 18 | 10.0 | 13.60 | 2.860 | 375.52% |
| 2021-04-12 | 5 | 18 | 10.0 | 13.60 | 2.820 | 382.27% |
| 2021-04-10 | 5 | 18 | 10.0 | 13.60 | 3.010 | 351.83% |
| 2021-04-03 | 5 | 18 | 10.0 | 13.60 | 3.180 | 327.67% |
| 2021-03-20 | 5 | 18 | 10.0 | 13.60 | 3.410 | 298.83% |
| 2021-03-11 | 5 | 18 | 10.0 | 13.60 | 3.260 | 317.18% |
| 2021-03-06 | 5 | 18 | 10.0 | 13.60 | 3.080 | 341.56% |
| 2021-02-27 | 5 | 18 | 10.0 | 13.20 | 3.890 | 239.33% |
| 2021-02-20 | 5 | 18 | 10.0 | 13.20 | 4.200 | 214.29% |
| 2021-02-13 | 5 | 18 | 10.0 | 13.20 | 4.330 | 204.85% |
| 2021-02-06 | 5 | 18 | 10.0 | 13.20 | 4.355 | 203.1% |
| 2021-01-30 | 5 | 18 | 10.0 | 13.20 | 3.960 | 233.33% |
| 2021-01-23 | 5 | 18 | 10.0 | 13.20 | 4.200 | 214.29% |
| 2021-01-16 | 5 | 18 | 10.0 | 13.00 | 3.920 | 231.63% |
| 2021-01-07 | 5 | 19 | 10.0 | 13.80 | 4.210 | 227.79% |
| 2020-12-30 | 5 | 19 | 10.0 | 13.80 | 4.270 | 223.19% |
| 2020-12-26 | 5 | 19 | 10.0 | 13.80 | 4.580 | 201.31% |
| 2020-12-19 | 5 | 19 | 10.0 | 13.80 | 4.570 | 201.97% |
| 2020-12-10 | 5 | 19 | 10.0 | 13.80 | 4.660 | 196.14% |
| 2020-12-07 | 5 | 19 | 10.0 | 13.80 | 4.620 | 198.7% |
| 2020-11-28 | 5 | 19 | 10.0 | 13.80 | 4.260 | 223.94% |
| 2020-11-13 | 5 | 19 | 10.0 | 13.80 | 3.990 | 245.86% |
| 2020-11-06 | 5 | 19 | 8.0 | 13.40 | 4.040 | 231.68% |
| 2020-10-25 | 5 | 19 | 8.0 | 13.60 | 3.880 | 250.52% |
| 2020-09-19 | 5 | 19 | 8.0 | 13.60 | 5.430 | 150.46% |
| 2020-08-12 | 5 | 19 | 8.0 | 13.60 | 4.440 | 206.31% |
| 2020-07-06 | 4 | 19 | 11.0 | 16.25 | NA | NA% |
| 2020-06-26 | 4 | 22 | 11.0 | 17.00 | NA | NA% |
| 2020-06-25 | 4 | 22 | 10.0 | 15.00 | NA | NA% |
| 2020-05-28 | 5 | 18 | 10.0 | 12.40 | NA | NA% |
CHMA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.7 | 0 | 3 | 2 | 0 | 0 | 5 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Chiasma Inc's variance in analysts' estimates is less than 1.20999999999999% of all US stocks.
- CHMA has a higher upside potential (average analyst target price relative to current price) than 86.6% of all US stocks.
- The average analyst price target of CHMA is greater than 17.32% of all US stocks.
- CHMA has a greater number of analysts covering the stock than 69.24% of stocks in the small market cap category.
Stocks similar to Chiasma Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CRVS, STSA and ZIOP.
Is CHMA a Buy, Hold or Sell? See the POWR Ratings now!